ATE243532T1 - Verfahren zur bewertung von chemotherapeutischen mitteln in vivo - Google Patents

Verfahren zur bewertung von chemotherapeutischen mitteln in vivo

Info

Publication number
ATE243532T1
ATE243532T1 AT94914886T AT94914886T ATE243532T1 AT E243532 T1 ATE243532 T1 AT E243532T1 AT 94914886 T AT94914886 T AT 94914886T AT 94914886 T AT94914886 T AT 94914886T AT E243532 T1 ATE243532 T1 AT E243532T1
Authority
AT
Austria
Prior art keywords
vivo
chemotherapeutic agents
evaluation
test agent
laboratory animal
Prior art date
Application number
AT94914886T
Other languages
English (en)
Inventor
Melinda Hollingshead
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE243532T1 publication Critical patent/ATE243532T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT94914886T 1993-05-05 1994-04-21 Verfahren zur bewertung von chemotherapeutischen mitteln in vivo ATE243532T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/058,154 US5698413A (en) 1993-05-05 1993-05-05 Method of evaluating chemotherapeutic agents in vivo
PCT/US1994/004443 WO1994025074A1 (en) 1993-05-05 1994-04-21 Method of evaluating chemotherapeutic agents in vivo

Publications (1)

Publication Number Publication Date
ATE243532T1 true ATE243532T1 (de) 2003-07-15

Family

ID=22015035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94914886T ATE243532T1 (de) 1993-05-05 1994-04-21 Verfahren zur bewertung von chemotherapeutischen mitteln in vivo

Country Status (8)

Country Link
US (1) US5698413A (de)
EP (1) EP0697892B1 (de)
JP (1) JPH08512292A (de)
AT (1) ATE243532T1 (de)
AU (1) AU697146B2 (de)
CA (1) CA2162165C (de)
DE (1) DE69432861T2 (de)
WO (1) WO1994025074A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042909A (en) * 1997-09-03 2000-03-28 Circe Biomedical, Inc. Encapsulation device
US6022733A (en) * 1997-12-02 2000-02-08 Tam; Yun K. Simulated biological dissolution and absorption system
ATE267875T1 (de) 1999-03-09 2004-06-15 Acordis Ind Fibers Gmbh Membranmodul zum testen von wirkstoffen an zellen
US6616912B2 (en) 2001-01-05 2003-09-09 Spectrum Laboratories, Inc. Bi-component microporous hollow fiber membrane structure for in vivo propagation of cells
EP1364206A2 (de) * 2001-01-09 2003-11-26 Novartis AG Schnelles screening-verfahren für in vivo wirksame verbindungen
WO2003046139A2 (en) * 2001-11-26 2003-06-05 Exelixis, Inc. CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
KR20050004263A (ko) * 2002-05-30 2005-01-12 레이븐 바이오테크놀로지스, 인코퍼레이티드 독물학 및 투여량 예측을 위한 동물 모델
EP1656447A2 (de) * 2003-05-29 2006-05-17 AstraZeneca AB Testen des zellzyklusregulationseffekts einer verbindung unter verwendung eines hohlfaser-zellimplantats
JP5251876B2 (ja) * 2007-07-24 2013-07-31 アステラス製薬株式会社 ベンズイミダゾール誘導体
AU2008287427B2 (en) 2007-08-13 2014-10-09 Vasgene Therapeutics, Inc. Cancer treatment using humanized antibodies that bind to EphB4
JP2010540534A (ja) * 2007-09-28 2010-12-24 イントレキソン コーポレーション 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用
AU2009302804B2 (en) 2008-10-08 2015-07-02 Intrexon Corporation Engineered cells expressing multiple immunomodulators and uses thereof
JPWO2010087319A1 (ja) * 2009-01-27 2012-08-02 アステラス製薬株式会社 前立腺癌治療剤として有効な物質のスクリーニング方法
JP6895674B2 (ja) * 2015-10-21 2021-06-30 国立大学法人 東京大学 マイクロチューブ、マイクロチューブの製造方法、及びマイクロチューブの製造装置
CN107976534A (zh) * 2016-10-21 2018-05-01 上海立迪生物技术股份有限公司 一种抗肿瘤药物快速药效筛选方法及其专用装置
CN115803062A (zh) 2020-06-03 2023-03-14 博泰康医药公司 滋养层细胞表面抗原2(trop-2)抗体
WO2022010797A2 (en) 2020-07-07 2022-01-13 Bionecure Therapeutics, Inc. Novel maytansinoids as adc payloads and their use for the treatment of cancer
WO2022159984A1 (en) 2021-01-22 2022-07-28 Bionecure Therapeutics, Inc. Anti-her-2/trop-2 constructs and uses thereof
CN117660581A (zh) * 2022-09-01 2024-03-08 上海立迪生物技术股份有限公司 一种筛选免疫调节药物药效的模型及方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759911A (fr) * 1969-12-05 1971-05-17 Worthington Biochem Corp Produits enzymatiques actifs
US4324683A (en) * 1975-08-20 1982-04-13 Damon Corporation Encapsulation of labile biological material
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4495288A (en) * 1981-03-13 1985-01-22 Damon Biotech, Inc. Method of culturing anchorage dependent cells
CA1265443A (en) * 1985-09-18 1990-02-06 Elieser Gorelik Assays for chemotherapeutic agents
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5416022A (en) * 1988-08-10 1995-05-16 Cellex Biosciences, Inc. Cell culture apparatus
AU7656991A (en) * 1990-03-30 1991-10-30 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method and composition for growing tumors from few cells
JP3252361B2 (ja) * 1991-10-02 2002-02-04 ミルトン・エイチ・リプスキー インビボにおける癌の治療のアッセイ

Also Published As

Publication number Publication date
CA2162165C (en) 2008-07-08
DE69432861T2 (de) 2004-05-19
EP0697892A1 (de) 1996-02-28
WO1994025074A1 (en) 1994-11-10
US5698413A (en) 1997-12-16
AU697146B2 (en) 1998-10-01
EP0697892B1 (de) 2003-06-25
DE69432861D1 (de) 2003-07-31
CA2162165A1 (en) 1994-11-10
AU6711594A (en) 1994-11-21
JPH08512292A (ja) 1996-12-24

Similar Documents

Publication Publication Date Title
ATE243532T1 (de) Verfahren zur bewertung von chemotherapeutischen mitteln in vivo
DE69816272D1 (de) Cyanidfreie lytische reagenzzusammensetzung und verfahren zur hämoglobin- und zellanalyse
DE3853254D1 (de) Ausrüstungssatz und Verfahren für Analysen von biologischen Proben.
DE69717632T2 (de) Vorrichtung und verfahren zur echtzeitmessung der zellularen reaktion
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
DE3752020D1 (de) Spektrometerobjektiv für Korpuskularstrahlmessgeräte und Verfahren zur Untersuchung von Proben.
ATE298887T1 (de) Verfahren zum nachweis solider krebszellen und histologischer heterotypien und verfahren zur prüfung von gewebe für die knochenmarktransplantation und die transplantation von peripheren blutstammzellen
NO20004451L (no) FremgangsmÕte for Õ utføre telling av blodceller
ATE239912T1 (de) Verfahren und vorrichtung zur referenzierung von fluoreszenzintensitätssignalen
DE3887168D1 (de) Verfahren zur quantitativen analyse von mineralien.
DK0535005T3 (da) Forbedret fremgangsmåde og apparat til indføring af biologiske substanser i levende celler
DE69026024D1 (de) Künstlicher Träger zur Immobilisierung von biologischen Proteinen und Verfahren zu seiner Herstellung
ATE428928T1 (de) Verfahren zur einführung von heterologischen zellen in fische
DE69808930T2 (de) Leberfunktionstest
DE3885733D1 (de) Verfahren zur befreiung von zellgemischen und geweben von unerwünschten populationen.
DE59009864D1 (de) Verfahren und Schaltung zur Auswertung von kontinuierlich auftretenden Zeitmarken.
DE69028104D1 (de) Verfahren zur proteinbindung-enzym-komplementationstests
DE3678621D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxyd.
DE69007934D1 (de) Verankerung für Spannglied und Verfahren zu seiner Herstellung.
ATE333519T1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
ATE5200T1 (de) Verfahren und reagens zur bestimmung von betalactamasen.
ATE269417T1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren
DE69635925D1 (de) Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren
ATE7049T1 (de) Verfahren zur bestimmung der gammaglutamyltranspeptidase.
ATE208505T1 (de) Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties